Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18630InvestigationalCell transplant therapies
Allogeneic natural killer cells: Overview.
- Also known as
- Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells
What you can answer from here — as of April 23, 2025
Which companies are running trials of Allogeneic natural killer cells, in which indications and phases, and which of those programs are still active?